Associate Director, Group Leader, BeOne Institute
BeiGene
Summary
At BeOne Institute, we extend BeOne's execution strength with a dedicated innovation engine, bringing agility and scientific depth to transform uncertainty into actionable and high-impact therapeutic opportunities. We operate according to three core principles: Bold Exploration, Strategic Alignment, and Pipeline Impact.
Job description
As a Group Leader at BeOne Institute, you will lead a high-performing research team to advance breakthrough discoveries. You will set and execute a forward-looking research strategy aligned with our mission, foster a collaborative environment where innovative ideas are translated into transformative medicines.
Job Responsibilities
- Drive scientific excellence and delivery by establishing clear program goals and milestones.
- Communicate progress through regular updates while proactively identifying challenges and proposing solutions.
- Build and develop a high-performing team and foster team members' professional growth, technical expertise, and scientific independence.
- Lead cross-disciplinary or cross-functional collaborations and drive innovation within and beyond the Institute.
Requirements
- Ph.D., M.D., or equivalent advanced degree with deep expertise in one or more of the following areas: cancer biology, cancer immunology, immunology, protein engineering, AI-driven protein design, or a related life sciences discipline.
- Substantial post-degree professional experience in academia and/or industry, with a strong track record of contributions to drug discovery or impactful scientific achievements.
- Ability to operate effectively in a highly collaborative, fast-paced, and interdisciplinary research environment, and to integrate multi-disciplinary approaches to solve complex biological problems.
- Scientific leadership to build and sustain collaborative relationships across functional and disciplinary boundaries.
- Experience of providing scientific guidance and mentorship in a collaborative team environment.
- Excellent communication and presentation skills, with the ability to clearly articulate complex scientific concepts to both technical and non-technical audiences.
Supervisory Responsibilities: Yes. Travel: No.
Requirements
- Ph.D., M.D., or equivalent advanced degree
- Deep expertise in cancer biology, cancer immunology, immunology, protein engineering, AI-driven protein design, or related life sciences discipline
- Substantial post-degree professional experience in academia and/or industry
- Strong track record of contributions to drug discovery or impactful scientific achievements
- Ability to work in a highly collaborative, fast-paced, interdisciplinary research environment
- Scientific leadership across functional and disciplinary boundaries
- Experience providing scientific guidance and mentorship
- Excellent communication and presentation skills
- 5+ years of experience
- Must be able to work onsite in San Carlos, California
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual bonus plan
- Discretionary equity awards
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.